Clinical Trials on Monkeypox Virus Infection in Germany

Total 2739 results

University of Giessen

Active, not recruiting

Acute Kidney Injury and Acute Kidney Disease in COVID-19

Acute Kidney Injury | Corona Virus Infection

Germany
Gilead Sciences

Completed

Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

HCV Infection

United States, Germany, New Zealand
Novartis
Novartis Vaccines

Completed

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Encephalitis, Tick-Borne

Germany
Johann Wolfgang Goethe University Hospital

Unknown

Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns (MoChi-HCMV)

Materno-fetal Transfer of Anti-HCMV-IgG | Materno-fetal Transfer of Anti-VZV-IgG

Germany
Novartis
Novartis Vaccines

Completed

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Encephalitis, Tick-Borne

Germany
Carsten Müller-Tidow
German Federal Ministry of Education and Research; Institut für Klinische Transfusionsmedizin...

Recruiting

Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19 (RECOVER)

SARS-CoV-2 Infection

Germany
International AIDS Vaccine Initiative
Children's Hospital of Philadelphia; Nationwide Children's Hospital; Targeted...

Completed

Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine (A001)

HIV Infection

Belgium, Germany, India
Bavarian Nordic
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects

Smallpox

Germany
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older

Herpes Zoster

Germany, Canada, United States
Enanta Pharmaceuticals, Inc

Completed

Two-way Interaction Between Alisporivir and EDP239

Hepatitis C Virus

Germany
Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C123 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents Efavirenz and Raltegravir

Hepatitis C Virus

Germany
University Hospital, Bonn
Hoffmann-La Roche

Terminated

Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients

HIV Infections | Chronic Hepatitis B

Germany
University of Cologne
Boehringer Ingelheim; ZKS Köln

Completed

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation

SARS-CoV-2 Infection

Germany
Merck Sharp & Dohme LLC

Completed

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Cytomegalovirus Infection

United States, France, Germany, Italy, Japan, United Kingdom
Bavarian Nordic

Completed

Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects

Smallpox

Germany
Charite University, Berlin, Germany

Unknown

Exercise for Patients With HIV Infections

HIV Infections | Inflammation | Lipodystrophy

Germany
Marylyn Addo
Charite University, Berlin, Germany; University of Cologne; Ludwig-Maximilians... and other collaborators

Completed

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

MERS (Middle East Respiratory Syndrome)

Germany
Janssen Sciences Ireland UC

Completed

A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

Hepatitis B, Chronic

Belgium, United Kingdom, France, Italy, Germany, Spain, Poland
MUC Research GmbH
Merck Sharp & Dohme LLC; Pfizer; AbbVie; German Center for Infection Research

Completed

New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients (NewEra)

HIV Infections

Germany
Merck Sharp & Dohme LLC

Completed

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

Cytomegalovirus (CMV) Infection

United States, Australia, Colombia, France, Germany, Israel, Japan, Mexico, Poland, Spain, Turkey
Alexion
Achillion, a wholly owned subsidiary of Alexion

Completed

Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A

Human Immunodeficiency Virus (HIV)-1 Infection

United States, Spain, Germany, Dominican Republic
GlaxoSmithKline

Terminated

Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

HIV Infection

Germany
University of Ulm
Novartis

Withdrawn

Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B (EVD)

Hepatitis B, Chronic

Germany
Bristol-Myers Squibb

Completed

Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

Hepatitis B, Chronic

Germany
Dr. Alexander Supady

Completed

Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation (CYCOV)

COVID-19 | Respiratory Failure | SARS-CoV Infection | Coronavirus | Cytokine Storm

Germany
GlaxoSmithKline
Labtec GmbH

Completed

An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode

Herpes Labialis

Germany
University Hospital, Essen
Janssen Medical Affairs

Unknown

Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment Regimens

HIV-infection

Germany
Ruhr University of Bochum

Recruiting

DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections (HPV-VG1)

HPV Infection | Cervix Dysplasia

Germany
CureVac

Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

Rabies

Belgium, Germany
Janssen Sciences Ireland UC

Terminated

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection

Virus Diseases | Respiratory Syncytial Virus Infections

Australia, Spain, Belgium, Sweden, Netherlands, Brazil, Germany, Argentina, Philippines, United States
Janssen Sciences Ireland UC

Completed

An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection

Hepatitis B

United States, Korea, Republic of, France, Belgium, Italy, Taiwan, United Kingdom, Thailand, Malaysia, China, Spain, Canada, Germany, Japan, Russian Federation, Turkey, Ukraine, Poland, Hong Kong
University Hospital of Cologne
Humanizing Technologies GmbH; University of Applied Sciences Cologne

Not yet recruiting

Hybrid Interactive Avatars for Post-COVID Sufferers (HINT)

Post-Acute COVID-19 Syndrome

Germany
Valneva Austria GmbH

Completed

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis

Austria, Germany
Tibotec Pharmaceuticals, Ireland

Completed

A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

Human Immunodeficiency Virus Type 1

Germany
GlaxoSmithKline

Completed

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

Measles | Rubella | Mumps | Varicella

Germany
Novartis Vaccines

Completed

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects

Seasonal Influenza

Germany
Enzymatica AB
Analyze & Realize

Completed

Evaluation of the Use of Various Assessments of Common Cold Symptoms for Proof of Efficacy of ColdZyme Mouth Spray

Common Cold

Germany
Charite University, Berlin, Germany
Karl and Veronica Carstens Foundation

Completed

Effectiveness of Local Application of Warm Air in Patients With Common Cold (HELI Study) (HELI)

Common Cold

Germany
Charite University, Berlin, Germany
NSA, Collierville, TN, USA

Completed

Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms

Common Cold

Germany
Janssen R&D Ireland

Terminated

Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382

Chronic Hepatitis C Infection

Germany
University of Ulm

Withdrawn

Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients

Liver Diseases | Virus Diseases | Hepatitis C, Chronic

Germany
Schön Klinik Berchtesgadener Land

Completed

Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19 (STEPCO)

Quality of Life | Covid19 | Pulmonary Rehabilitation | SARS-CoV Infection

Germany
Technical University of Munich
Charite University, Berlin, Germany; University of Cologne; University of Hamburg-Eppendorf and other collaborators

Recruiting

Munich Long COVID Registry for Children, Adolescents, and Adults (MLC-R)

Post-COVID Condition

Germany
ModernaTX, Inc.

Completed

Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects

Influenza

Germany
Charite University, Berlin, Germany
Hoffmann-La Roche

Completed

Oseltamivir Infant Influenza Safety Study

Influenza, Human

Germany
Novartis Vaccines

Completed

Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects

Influenza

Germany
GlaxoSmithKline

Completed

Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03

Influenza

Germany
Hoffmann-La Roche

Completed

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Hepatitis B, Chronic

Germany
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Geneva; Wellcome Trust; KEMRI-Wellcome Trust Collaborative... and other collaborators

Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

Hemorrhagic Fever, Ebola

Germany
Seqirus
Novartis Vaccines

Completed

Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above

Influenza

Germany

3

Subscribe